Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESET: Octaplas LG vs Crystalloids in Pediatric Sepsis
NCT07035509Phase 4Not yet recruiting
- Sponsor
- Fundación Cardioinfantil Instituto de Cardiología
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of octaplas lg in sepsis, septic shock, sponsored by Fundación Cardioinfantil Instituto de Cardiología. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
octaplas lg
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT07035509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07035509.